Ixoreal Biomed highlights an exploratory placebo-controlled study of SRI-81 Shatavari, alone and combined with KSM-66 Ashwagandha, published in the International Journal of Women’s Health.
|Articles|October 21, 2010
Kemin Plans Five-Year Expansion
Kemin Industries (Des Moines, IA) plans to construct 6 new manufacturing facilities, 3 new research labs, and a new corporate building over the next five years, the company announced this week.
Advertisement
Kemin Industries (Des Moines, IA) plans to construct 6 new manufacturing facilities, 3 new research labs, and a new corporate building over the next five years, the company announced this week.
“As we approach our 50-year anniversary in 2011, we are pleased to be well-positioned to make this significant investment…Our expansion in Des Moines is an important part of the overall global expansion plan that will take the company to the next level,” said the company’s president and CEO Chris Nelson, PhD.
Advertisement
Related to this article
Clinical research moves beyond compliance, focusing on smarter trial design, risk-based quality, and “evidence engineering” to deliver decisive, decision-ready results.
The company says the innovation, built on its CoreNhanced BioJourney platform, is designed for beverage and gummy formats.
AuraFen, BILVORA, and IMBE debut at SupplySide Global 2026, and the company will also highlight its CaFi digestive health ingredient.
Horphag Research's Sébastien Bornet breaks down the clinical science behind Robuvit, exploring how the caffeine-free French oak extract supports mitochondrial energy, mood stability, and stress resilience.
Todd Harrison, co-chair of the FDA practice group at Venable LLP, explains how California’s AB 2779 changes date-labeling requirements for supplements, why stability testing matters, and how companies can navigate evolving state rules while advocating for federal uniformity.
FDA's final NDI guidance sets identity and safety expectations. See what AHPA and CRN say remains unresolved and what it means for suppliers.
The company plans to present Organicaps capsules in size 0, 25 years of UC-II, and liquid-filled capsule technology.
Advertisement
Advertisement
Trending on Nutritional Outlook - Supplement, Food & Beverage Manufacturing Trends
1
CoreFX Launches CreaSHLD-IN Shielded Creatine at SupplySide Global 2026
2
Navigating Supplement Ingredients and Claims Regulations in Europe, the US, and Canada
3
FDA Finalizes NDI Guidance on Identity and Safety Information, Leaving Some Industry Concerns Open
4
Lonza Capsugel to Feature Organicaps, UC-II, and Capsule Delivery Technologies at SupplySide Global 2026
5